Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by stanleyon Oct 23, 2013 8:42am
305 Views
Post# 21840147

RE:Sand storm agreement.

RE:Sand storm agreement.
Josa:

Here is the SSL link to the updated details of the SSL streaming agreement...With the recent interest in SSL warrants could that be an "expression of interest" in BRD's "re-rating" post bonanza grade announcement?

https://www.sandstormgold.com/news/release/index.php?content_id=245


I still SPECULATE that a re-rating of BRD pps in this EXTREMELY negative POG enviroment speaks volumes for BRD going foward especially in light of the delay of the "promised" release of the Grey Fox scoping study. See also the MineWeb article comments by Howard Bird and the recent comments attributed to Haywood's Kerry Smith P. Eng. All that is left is, "BRD is unaware of any developments that would explaing the recent activity in BRD shares"... Editor's note.. BRD recently announced some drilling results that analysts SPECULATE, could significant increase the 3I's at Black Fox, approximately 4km away from their Grey Fox property. There is also SPECULATION that BRD and SAS are crossing the "i's" and dotting the "t's" (LOL) of some business combination that COULD significantly reduce the CAPEX in the development of the GF/Hislop "superpit" & UG lenticular. Sometimes the delay in a promised announcement is directly attributable to the "meeting of the minds" of the parties working on "mining through/across a party wall".

BWDIK? New buyers appear to be responding to the BRD BF deep drilling announcement. The only thing that appears to be a technical challenge is where one article discussed the ramping. Historically, there is a 400m (1200 foot) inflection to shafting.

Cheers
Stanley

Bullboard Posts